Shares of Maximus, Inc. (NYSE:MMS) have received a consensus rating of “Hold” from the ten ratings firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating and seven have given a hold rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $61.00.

Several research firms have issued reports on MMS. BidaskClub cut shares of Maximus from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 6th. Canaccord Genuity reaffirmed a “buy” rating and set a $62.00 price target on shares of Maximus in a research note on Friday, April 7th. ValuEngine cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, May 16th. Jefferies Group LLC cut shares of Maximus from a “buy” rating to a “hold” rating and raised their price target for the stock from $63.00 to $64.00 in a research note on Friday, May 5th. Finally, Maxim Group cut shares of Maximus from a “buy” rating to a “hold” rating and set a $66.00 price target on the stock. in a research note on Thursday, May 4th. They noted that the move was a valuation call.

Shares of Maximus (NYSE:MMS) traded up 1.72% during trading on Tuesday, reaching $61.56. 557,808 shares of the company were exchanged. Maximus has a 1-year low of $43.69 and a 1-year high of $64.97. The company’s 50-day moving average is $62.34 and its 200 day moving average is $60.58. The firm has a market capitalization of $3.99 billion, a PE ratio of 20.18 and a beta of 1.40.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, May 4th. The health services provider reported $0.80 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.02. Maximus had a net margin of 8.18% and a return on equity of 26.21%. The firm had revenue of $622 million during the quarter, compared to the consensus estimate of $620.24 million. During the same period last year, the firm posted $0.74 EPS. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities research analysts expect that Maximus will post $3.05 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 31st. Investors of record on Tuesday, August 15th will be given a $0.045 dividend. The ex-dividend date of this dividend is Friday, August 11th. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. Maximus’s dividend payout ratio is presently 5.86%.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/07/25/maximus-inc-nysemms-receives-consensus-rating-of-hold-from-brokerages.html.

In related news, General Counsel David Francis sold 1,000 shares of Maximus stock in a transaction on Friday, July 14th. The shares were sold at an average price of $60.46, for a total value of $60,460.00. Following the completion of the sale, the general counsel now owns 15,715 shares in the company, valued at $950,128.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $61.79, for a total transaction of $494,320.00. Following the completion of the sale, the president now owns 35,904 shares of the company’s stock, valued at approximately $2,218,508.16. The disclosure for this sale can be found here. Insiders sold 109,846 shares of company stock worth $6,893,986 in the last 90 days. 3.10% of the stock is currently owned by insiders.

Several hedge funds have recently modified their holdings of MMS. Two Sigma Investments LP acquired a new position in Maximus during the fourth quarter worth approximately $258,000. American International Group Inc. increased its position in shares of Maximus by 4.1% in the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock valued at $10,366,000 after buying an additional 6,634 shares during the period. Louisiana State Employees Retirement System increased its position in shares of Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock valued at $1,020,000 after buying an additional 400 shares during the period. Navellier & Associates Inc increased its position in shares of Maximus by 10.9% in the first quarter. Navellier & Associates Inc now owns 8,737 shares of the health services provider’s stock valued at $543,000 after buying an additional 856 shares during the period. Finally, Advantus Capital Management Inc increased its position in shares of Maximus by 3.1% in the first quarter. Advantus Capital Management Inc now owns 8,298 shares of the health services provider’s stock valued at $516,000 after buying an additional 248 shares during the period. Institutional investors and hedge funds own 97.89% of the company’s stock.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Analyst Recommendations for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.